CenterPoint Energy, Inc. CNP
39.80 USD -0.88 (-2.16%)
Regular-session close
39.80 0.00 0.00%
After hours · Nov 17, 4:00 PM ET
39.79 Day range 40.56
36.37 52-week range 45.26
- YTD
- +3.81%
- 1 year
- -0.95%
News
benzinga.com Evercore ISI Group Maintains In-Line on CenterPoint Energy, Lowers Price Target to $41 Evercore ISI Group analyst Nicholas Amicucci maintains CenterPoint Energy (NYSE:CNP) with a In-Line and lowers the price target from $43 to $41.
defenseworld.net CenterPoint Energy, Inc. $CNP Stock Sold by Allspring Global Investments Holdings LLC Allspring Global Investments Holdings LLC cut its position in CenterPoint Energy, Inc. (NYSE: CNP) by 7.2% in the undefined quarter, according to its most recent disclosure with the Securities and…
globenewswire.com Ascendis Pharma Reports Third Quarter 2026 Financial Results Q3 2026 product revenue of €366 million (+89% Y/Y), comprising €291 million for YORVIPATH ® , €59 million for SKYTROFA ® , and €16 million for YUVIWEL ® Received positive CHMP and COMP opinions…
seekingalpha.com Elite Dividend Growth Machines On Sale (Up To 7% Yields) Diversified ETFs and CEFs can offer investors a powerful combination of attractive current income, long-term dividend growth, and reduced company-specific risk. Two dividend growth machines currently…
globenewswire.com Once-Weekly TransCon® CNP (Navepegritide) to Receive 10 Years of Market Exclusivity Upon Approval in the European Union – Final European Commission decision expected during Q4 2026 COPENHAGEN, Denmark, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Committee for Orphan…
defenseworld.net CenterPoint Energy (NYSE:CNP) Stock Sees Heavy Put Option Buying CenterPoint Energy, Inc. (NYSE: CNP - Get Free Report) was the target of some unusual options trading on Tuesday. Investors acquired 10,004 put options on the stock. This is an increase of…
defenseworld.net Dominion Energy (NYSE:D) & CenterPoint Energy (NYSE:CNP) Head to Head Analysis Dominion Energy (NYSE: D - Get Free Report) and CenterPoint Energy (NYSE: CNP - Get Free Report) are both large-cap utilities companies, but which is the better investment? We will compare the two…
fool.com CenterPoint Energy: 3 Key Takeaways for Long-Term Investors CenterPoint Energy increased its 10-year capital plan by $4 billion. The company expects annual rate base growth of over 14% through 2030.
defenseworld.net Reviewing WEC Energy Group (NYSE:WEC) and CenterPoint Energy (NYSE:CNP) CenterPoint Energy (NYSE: CNP - Get Free Report) and WEC Energy Group (NYSE: WEC - Get Free Report) are both large-cap utilities companies, but which is the superior investment? We will compare the…
barrons.com AI Data Centers Are on the Ballot. 7 Stocks That Are at Risk. Polls have found that Americans think data centers inflate home energy costs and are bad for the environment.benzinga.com Barclays Maintains Equal-Weight on CenterPoint Energy, Raises Price Target to $43 Barclays analyst Nicholas Campanella maintains CenterPoint Energy (NYSE:CNP) with a Equal-Weight and raises the price target from $41 to $43.
seekingalpha.com CenterPoint Energy's Growth Outlook Remains Bright CenterPoint Energy remains a "Buy," underpinned by robust Houston metro growth and disciplined cost management. CNP raised 2023 EPS guidance to $1.90–$1.92 and initiated 2027 guidance at $2.07–$2.09,…
zacks.com CenterPoint Energy Q3 Earnings Beat Estimates, Revenues Improve Y/Y CNP beats Q3 2026 earnings and revenue estimates, with sales rising 10.2% year over year, and raises its full-year adjusted EPS guidance.
seekingalpha.com CenterPoint Energy, Inc. (CNP) Q3 2026 Earnings Call Transcript CenterPoint Energy, Inc. (CNP) Q3 2026 Earnings Call Transcript
marketbeat.com What CenterPoint Energy (CNP) Said on Its Q3 Earnings Call CenterPoint Energy NYSE: CNP raised its 2026 adjusted earnings guidance and expanded its long-term capital plan, citing accelerating customer demand in the Greater Houston area and additional…
zacks.com Here's What Key Metrics Tell Us About CenterPoint (CNP) Q3 Earnings Although the revenue and EPS for CenterPoint (CNP) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
benzinga.com CenterPoint Energy Q3 2026 Earnings Call Transcript CenterPoint Energy (NYSE:CNP) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…
zacks.com CenterPoint Energy (CNP) Q3 Earnings and Revenues Top Estimates CenterPoint Energy (CNP) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.5 per share a year ago.benzinga.com CenterPoint Energy Extends Adjusted EPS Growth At The Mid-To-High End Of Its 7%-9% Annual Range Through 2030 Increases 10-year capital plan by $4.0 billion to $70.7 billion and accelerates $1.5 billion of investment into 2026-2030, supporting a rate base CAGR of more than 14% through 2030
benzinga.com CenterPoint Energy Q3 Adj. EPS $0.53 Beats $0.49 Estimate, Sales $2.191B Beat $2.173B Estimate CenterPoint Energy (NYSE:CNP) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.49 by 8.16 percent. This is a 6 percent increase over earnings of $0.50…
businesswire.com CenterPoint Energy Reports Strong Q3 2026 Results; Raises Earnings Guidance and Increases Capital Plan; Extends Higher Growth Outlook Through 2030 HOUSTON--(BUSINESS WIRE)--CenterPoint Energy, Inc. (NYSE: CNP), or “CenterPoint,” today reported net income of $331 million, or $0.50 per diluted share, on a GAAP basis for the third quarter of 2026,…benzinga.com CenterPoint Energy Raises FY2026 Adj EPS Guidance from $1.89-$1.91 to $1.90-$1.92 vs $1.91 Est CenterPoint Energy (NYSE:CNP) raises FY2026 Adj EPS guidance from $1.89-$1.91 to $1.90-$1.92 vs $1.91 analyst estimate..
benzinga.com CenterPoint Energy Q3 Sales $2.191B Beat $2.173B Estimate CenterPoint Energy (NYSE:CNP) reported quarterly sales of $2.191 billion which beat the analyst consensus estimate of $2.173 billion by 0.84 percent. This is a 10.21 percent increase over sales of…
benzinga.com TD Cowen Initiates Coverage On CenterPoint Energy with Buy Rating, Announces Price Target of $47 TD Cowen analyst Shelby Tucker initiates coverage on CenterPoint Energy (NYSE:CNP) with a Buy rating and announces Price Target of $47.
benzinga.com HSBC Initiates Coverage On CenterPoint Energy with Buy Rating, Announces Price Target of $44 HSBC analyst Meike Becker initiates coverage on CenterPoint Energy (NYSE:CNP) with a Buy rating and announces Price Target of $44.
benzinga.com Morgan Stanley Maintains Equal-Weight on CenterPoint Energy, Raises Price Target to $39 Morgan Stanley analyst David Arcaro maintains CenterPoint Energy (NYSE:CNP) with a Equal-Weight and raises the price target from $38 to $39.
zacks.com CenterPoint Energy to Report Q3 Earnings: What's in the Cards? CNP's Q3 earnings are likely to benefit from grid investments, rising electricity demand and rate-base growth, while higher financing costs could offset gains.
defenseworld.net CenterPoint Energy, Inc. $CNP Shares Sold by Louisbourg Investments Inc. Louisbourg Investments Inc. lowered its position in shares of CenterPoint Energy, Inc. (NYSE: CNP) by 45.1% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned…
zacks.com CenterPoint Energy (CNP) Expected to Beat Earnings Estimates: Can the Stock Move Higher? CenterPoint (CNP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.benzinga.com Barclays Maintains Equal-Weight on CenterPoint Energy, Lowers Price Target to $41 Barclays analyst Nicholas Campanella maintains CenterPoint Energy (NYSE:CNP) with a Equal-Weight and lowers the price target from $44 to $41.
benzinga.com BMO Capital Maintains Outperform on CenterPoint Energy, Lowers Price Target to $45 BMO Capital analyst James Thalacker maintains CenterPoint Energy (NYSE:CNP) with a Outperform and lowers the price target from $48 to $45.
globenewswire.com Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children COPENHAGEN, Denmark, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines…reuters.com Iran War The U.S. and Israel’s attack on Iran is the most consequential military operation in the Middle East in more than two decades. ago Trump and Tehran gamble on time as Iran war stalemate deepens After…
finance.yahoo.com Klarna Group plc (KLAR) The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for…
finance.yahoo.com USA Rare Earth, Inc. (USAR) The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for…
finance.yahoo.com Expand Energy Corporation (EXE) The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for…
finance.yahoo.com GE Vernova Inc. (GEV) The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for…
finance.yahoo.com Solventum Corporation (SOLV) The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for…
247wallst.com Centerpoint Energy Inc Looking ahead to 2030, our model projects CNP could trade at an average price of $59.33, with a potential range between $44.49 and $74.16. This represents a potential 46.1% return from today’s price.
uk.news.yahoo.com Donald Trump’s Meeting With Angelina Jolie’s Father Draws Fresh Scrutiny Donald Trump’s decision to spend time with Hollywood figures while the nation’s airports ground to a halt has raised ...
yahoo.com Vice President JD Vance Claims There’s No Need for Americans to ‘Prepare for the Worst’ Vice President JD Vance is attempting to calm Americans who feel the need to stockpile and prepare for a global crisis. “A ...
finance.yahoo.com BioMarin Pharmaceutical Sees $2.6 Billion Sales Potential in Amicus Drugs as VOXZOGO Expansion Looms BioMarin Pharmaceutical (NASDAQ:BMRN) expects growth from its acquired rare disease treatments, an expanded market for ...
yahoo.com Donald Trump’s Meeting With Angelina Jolie’s Father Draws Fresh Scrutiny Donald Trump’s decision to spend time with Hollywood figures while the nation’s airports ground to a halt has raised ...
finance.yahoo.com Rack Room Shoes Announces Chief Financial Officer Transition Patrick Edwards named Senior Vice President and Chief Financial Officer as longtime CFO Ernie Shore prepares to retire after ...
wonderwall.com Donald Trump's former White House Press Secretary Sean Spicer says it 'kills' him that the president 'goes back to these legacy outlets and gives them credibility' -- 'I… Former White House press secretary Sean Spicer criticized President Donald Trump for continuing to appear on traditional ...
msn.com 5 'self-made' billionaires who actually started out rich Here’s a look at how some well-known billionaires (and one trillionaire) started out, and why there aren’t really any rags-to ...
marketscreener.com Pulsar Helium Secures Final TSXV Acceptance for Plant Equipment Supply Pulsar Helium has secured final acceptance from the TSX Venture Exchange for the supply of equipment for its proposed rare ...
seekingalpha.com BioMarin Pharmaceutical Inc. (BMRN) Presents at Jefferies Global Healthcare Conference 2026 Transcript For those of you that don't know BioMarin, we are a rare disease -- global rare disease leader at scale. Okay. Good. Yes. So we're in 80 countries. Next year will be our 30th anniversary. We now have…
seekingalpha.com BridgeBio Pharma, Inc. (BBIO) Presents at Jefferies Global Healthcare Conference 2026 Transcript Jefferies Global Healthcare Conference 2026 November 16, 2026 4:30 AM ESTCompany ParticipantsNeil Kumar - Co-Founder, ...
marketscreener.com Pulsar Helium Secures TSX Venture Exchange's Approval for US Equipment Supply Deal Pulsar Helium received final approval from the TSX Venture Exchange for an $85.5 million equipment supply agreement with ...
